You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
| Title |
Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS)
|
|---|---|
| Published in |
CNS Neuroscience & Therapeutics, April 2013
|
| DOI | 10.1111/cns.12101 |
| Pubmed ID | |
| Authors |
Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, Adam Czaplinski, Florian Deisenhammer, Tobias Derfuss, Tanja H. Fabjan, Franz Fazekas, Siegrid Fuchs, Eva Havrdova, Alenka Horvath Ledinek, Zsolt Illes, Sasa Sega Jazbec, Eleonora Klimova, Samuel Komoly, Egon Kurca, Michael Linnebank, Lubomir Lisy, Jan Mares, Lubica Prochazkova, Rozsa Csilla, Jarmila Szilasiova, Pavel Stourac, Radomir Talab, Peter Turcani, Marta Vachova, Laszlo Vecsei, David Vodusek, Olga Zapletalova, Thomas Berger |
| Abstract |
Prolonged-release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary of data on fampridine PR and recommendations on practical use of the medication in clinical practice, prediction, and evaluation of response to treatment and patient management. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 3% |
| Canada | 1 | 3% |
| Unknown | 36 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 18% |
| Student > Ph. D. Student | 7 | 18% |
| Professor | 4 | 11% |
| Professor > Associate Professor | 3 | 8% |
| Other | 2 | 5% |
| Other | 4 | 11% |
| Unknown | 11 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 29% |
| Neuroscience | 6 | 16% |
| Psychology | 3 | 8% |
| Nursing and Health Professions | 2 | 5% |
| Social Sciences | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 13 | 34% |